Assessing the Challenges That Lie Ahead for Pharmacists as We Move Into the Third Year of the COVID-19 Pandemic

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses the challenges that lie ahead as we move into the third year of the COVID-19 pandemic, as well as other major developments on the horizon for pharmacists in 2022.

Pharmacy Times interviewed Ronald T. Piervincenzi, PhD, the CEO of US Pharmacopeia (USP), on reflections from 2021 and predictions for 2022.

The discussion is the seventh in a video series collaboration between Pharmacy Times and USP that highlights USP’s work to support the pharmacist and discussed USP’s perspective on timely and topical issues in the field.

In this video, Piervincenzi discusses the challenges that still lie ahead as we move into the third year of the COVID-19 pandemic in 2022 and other major developments that may be on the horizon for pharmacists in the new year.